Viking Therapeutics, Inc. - COMMON STOCK (VKTX)

Q4 2019 13F Holders as of 31 Dec 2019

Type / Class
Equity / COMMON STOCK
Shares outstanding
113,177,462
Total 13F shares
39,771,461
Share change
-978,375
Total reported value
$318,974,059
Put/Call ratio
63%
Price per share
$8.02
Number of holders
134
Value change
-$5,272,426
Number of buys
57
Number of sells
67

Institutional Holders of Viking Therapeutics, Inc. - COMMON STOCK (VKTX) as of Q4 2019

As of 31 Dec 2019, Viking Therapeutics, Inc. - COMMON STOCK (VKTX) was held by 134 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 39,771,461 shares. The largest 10 holders included ArrowMark Colorado Holdings LLC, BlackRock Inc., STATE STREET CORP, VANGUARD GROUP INC, FMR LLC, Park West Asset Management LLC, FIERA CAPITAL CORP, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, and Sio Capital Management, LLC. This page lists 134 institutional shareholders reporting positions in this security for the Q4 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.